EBITDA: Income before interest, taxes, depreciation and amortization.
Nanobiotix S.A. Sponsored ADR (NBTX) had EBITDA of $-72.25M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$-7.78M |
|
$-73.73M |
|
-- |
|
$-7.78M |
|
$66.23M |
|
$-74.01M |
|
$0.39M |
|
$-73.62M |
|
$-73.62M |
|
$-73.73M |
|
$-73.73M |
|
$-73.73M |
|
$-73.73M |
|
$-74.01M |
|
|
EBITDA |
$-72.25M |
47.27M |
|
47.27M |
|
$-1.56 |
|
$-1.56 |
|
| Balance Sheet Financials | |
$66.51M |
|
$5.99M |
|
$6.44M |
|
$72.95M |
|
$63.77M |
|
-- |
|
$80.28M |
|
$144.05M |
|
$-71.10M |
|
$-71.11M |
|
$-71.10M |
|
47.43M |
|
| Cash Flow Statement Financials | |
$-21.16M |
|
$-1.03M |
|
$-5.56M |
|
$81.46M |
|
$53.82M |
|
$-27.64M |
|
$4.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
951.09% |
|
951.09% |
|
928.55% |
|
946.06% |
|
947.46% |
|
$-22.07M |
|
-- |
|
-- |
|
-- |
|
-0.11 |
|
-- |
|
-2.42 |
|
-151.11 |
|
103.70% |
|
103.68% |
|
-101.06% |
|
103.70% |
|
$-1.50 |
|
$-0.47 |
|
$-0.45 |
|